BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20974014)

  • 1. Molecular mechanisms of pluripotency and reprogramming.
    Na J; Plews J; Li J; Wongtrakoongate P; Tuuri T; Feki A; Andrews PW; Unger C
    Stem Cell Res Ther; 2010 Oct; 1(4):33. PubMed ID: 20974014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.
    Kashyap V; Rezende NC; Scotland KB; Shaffer SM; Persson JL; Gudas LJ; Mongan NP
    Stem Cells Dev; 2009 Sep; 18(7):1093-108. PubMed ID: 19480567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Oct4-GFP spermatogonial stem cell line and its application in the reprogramming studies.
    Youn H; Kim SH; Choi KA; Kim S
    J Cell Biochem; 2013 Apr; 114(4):920-8. PubMed ID: 23097321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
    Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
    Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells.
    Fong YW; Inouye C; Yamaguchi T; Cattoglio C; Grubisic I; Tjian R
    Cell; 2011 Sep; 147(1):120-31. PubMed ID: 21962512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog.
    Yang VS; Carter SA; Hyland SJ; Tachibana-Konwalski K; Laskey RA; Gonzalez MA
    Curr Biol; 2011 Apr; 21(8):692-9. PubMed ID: 21497086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
    Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
    RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review).
    She S; Wei Q; Kang B; Wang YJ
    Mol Med Rep; 2017 Nov; 16(5):6459-6466. PubMed ID: 28901500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional foundation of pluripotency.
    Chambers I; Tomlinson SR
    Development; 2009 Jul; 136(14):2311-22. PubMed ID: 19542351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
    Barrand S; Collas P
    Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
    Fong H; Hohenstein KA; Donovan PJ
    Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene dynamics of core transcription factors for pluripotency in embryonic stem cells.
    David BG; Okamoto K; Kakizuka T; Ichimura T; Watanabe TM; Fujita H
    J Biosci Bioeng; 2015 Apr; 119(4):406-9. PubMed ID: 25441442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular coupling of Tsix regulation and pluripotency.
    Navarro P; Oldfield A; Legoupi J; Festuccia N; Dubois A; Attia M; Schoorlemmer J; Rougeulle C; Chambers I; Avner P
    Nature; 2010 Nov; 468(7322):457-60. PubMed ID: 21085182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of ground-state pluripotency by allelic regulation of Nanog.
    Miyanari Y; Torres-Padilla ME
    Nature; 2012 Feb; 483(7390):470-3. PubMed ID: 22327294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: what lies beyond the paradigm shift.
    Cox JL; Rizzino A
    Exp Biol Med (Maywood); 2010 Feb; 235(2):148-58. PubMed ID: 20404029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin 6: a novel surface marker for characterizing mouse pluripotent stem cells.
    Wang L; Xue Y; Shen Y; Li W; Cheng Y; Yan X; Shi W; Wang J; Gong Z; Yang G; Guo C; Zhou Y; Wang X; Zhou Q; Zeng F
    Cell Res; 2012 Jun; 22(6):1082-5. PubMed ID: 22565286
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
    Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
    PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells.
    Zhang X; Zhang J; Wang T; Esteban MA; Pei D
    J Biol Chem; 2008 Dec; 283(51):35825-33. PubMed ID: 18957414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers.
    Thomson M; Liu SJ; Zou LN; Smith Z; Meissner A; Ramanathan S
    Cell; 2011 Jun; 145(6):875-89. PubMed ID: 21663792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.